Clinical trials
Stroke (CVA) or Transient Ischemic Attack clinical trials
Below are recruiting stroke (cva) or transient ischemic attack clinical trials, each written for real people, not researchers. We’re tracking 142 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06398366Enrolling by invitation
Heart tests to prevent another stroke
This study looks at how heart problems might cause strokes. If you had a stroke that doctors can't explain after many tests, this trial will do extra heart monitoring to find possible causes and help prevent another stroke.
Camden, New JerseyAges 18 years+ - NCT06096831Enrolling by invitation
Living with stroke: studying healthcare use over time
This study looks at how stroke survivors use healthcare services over time. It hopes to find ways to improve long-term support and care after a stroke.
HaifaAges 18 years+ - NCT03611816Recruiting
Biobank study for atrial fibrillation and stroke samples
This study collects and stores medical information and biological samples from people with atrial fibrillation (or certain types of stroke). It helps researchers better understand these conditions and may support future improvements in diagnosis or treatment.
Bourg-en-BresseAges 18 years+ - NCT07287436Recruiting
Watchman device to prevent stroke in atrial fibrillation
This trial tests a device called the WATCHMAN Elite, which is placed in a small pouch of the heart to close it and reduce stroke risk, potentially allowing patients to stop blood thinners. It is for people with atrial fibrillation who cannot or prefer not to take long-term blood thinners.
Jonesboro, ArkansasAges 18 years+ - NCT05238610Recruiting
Registry for older adults with stroke of unclear cause and PFO
This study follows adults over 60 who had a stroke where the cause is unclear, and where a heart opening (PFO) may have contributed. It mainly collects information to better understand this stroke pattern and how these patients do over time.
SeoulAges 60 years+ - NCT06108414RecruitingPhase 4
Low-dose vs standard-dose blood thinner for older adults with atrial fibrillation
This trial tests whether a lower dose of the blood thinner rivaroxaban works as well as the standard dose for people 70 and older with atrial fibrillation (an irregular heartbeat). The goal is to find the safest dose to prevent strokes while reducing bleeding risks.
Beijing, Beijing MunicipalityAges 70 years+ - NCT07619885RecruitingPhase 1
Testing a New Blood Thinner Called CG-0255 in Healthy People
This study tests how a new blood-thinning medication (CG-0255) works in the body and compares it with Plavix, a common blood thinner. Researchers will measure how much of the drug enters your bloodstream and what effects it has on your blood clotting ability.
Miami, FloridaAges 18–55 - NCT07441382Recruiting
Comparing treatments for frail older adults with atrial fibrillation
This study tests whether combining a heart procedure (catheter ablation) with a device to close the left atrial appendage (LAAO) is safer or better than blood thinners alone for frail patients 75 years or older with atrial fibrillation and high stroke risk. It aims to find a treatment that reduces stroke while lowering bleeding risks.
Guangzhou, GuangdongAges 75 years+ - NCT06313866Recruiting
Herbal sniffing therapy plus acupuncture for stroke-related thinking problems
This trial tests if combining traditional Chinese herbal sniffing therapy with electroacupuncture can improve memory and thinking after a stroke. It may help people who are still in the early recovery phase.
Hangzhou, ZhejiangAges Up to 70 years - NCT07349121Recruiting
Testing the Farapulse and Watchman devices together
This trial is for people who need both a special heart treatment called pulsed field ablation (FARAPULSE) and a device to close off a small pouch in the heart (WATCHMAN FLX Pro or WATCHMAN FLX) to prevent strokes. The study will see how well both procedures work when done together.
AalstAges 18 years+ - NCT07196878Recruiting
Ultrasound-guided nerve stimulation to improve walking after stroke
This study tests a new, non-surgical treatment using ultrasound and gentle electrical stimulation (like a tiny pulse) to help improve walking after a stroke. It is for people who have had a stroke and are still working on their walking in physical therapy.
Zaragoza, AragonAges 18–70 - NCT07185971Recruiting
Vision training system for chronic vision loss after brain injury
This study tests a device called PAVE that may help improve vision in people who have lost part of their sight due to stroke, brain injury, or brain surgery. It is for those with ongoing vision problems, not those with eye diseases.
Cedar Rapids, IowaAges 21–80 - NCT07135791Recruiting
Tracking daily fatigue in adults with brain injury or cerebral palsy
This study uses a smartphone app to track how fatigue changes throughout the day in adults with cerebral palsy or acquired brain injury. The goal is to better understand fatigue patterns so doctors can offer better support.
Glostrup MunicipalityAges 30–65 - NCT07091682Recruiting
A trial of a dissolvable heart stent for long blockages
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
ErfurtAges 18–80 - NCT07054060Recruiting
Surgery vs. Stenting for Recent Stroke Symptoms from a Narrowed Carotid Artery
This trial compares two procedures—surgery to remove plaque from a carotid artery or placing a stent to widen the artery—to see which is better for people who recently had warning signs or a small stroke due to a severe blockage. The goal is to find the safest and most effective way to prevent future strokes.
ParisAges 18 years+ - NCT06690684Enrolling by invitation
Finding new blood markers for heart disease
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
Shanghai, Jing 'an DistrictAges 30 years+ - NCT06605014Recruiting
Body alignment after stroke or mini-stroke
This study looks at how a stroke or mini-stroke affects the body's natural movement and alignment (called somatic dysfunction). Researchers want to see if there are common patterns of tightness or imbalance after a stroke, which could help guide future treatments.
Sacramento, CaliforniaAges 18 years+ - NCT06361537RecruitingPhase 3
Study of a C1 inhibitor medicine for HAE attacks
This trial tests a plasma-derived C1 esterase inhibitor to treat and prevent acute attacks in people with hereditary angioedema (HAE) types 1 or 2. It aims to see if the medicine can quickly relieve swelling episodes and reduce their frequency.
Centennial, ColoradoAges 2 years+ - NCT05953584RecruitingPhase 2
Etavopivat for preventing stroke risk in sickle cell children
This trial studies etavopivat to see if it can improve blood-flow measurements in the brain that predict future stroke risk in children with sickle cell disease. If you qualify, you would take the study medicine and be monitored with brain blood-flow testing.
Raipur, ChhattisgarhAges 12–16 - NCT05508035RecruitingPhase 3
Testing sacubitril/valsartan vs ramipril for heart failure
This trial compares two blood-pressure and heart-failure medicines: sacubitril/valsartan versus ramipril, to see which improves heart pumping and heart structure over time. It’s aimed at people with ischemic (blocked-artery) heart failure with mid-range ejection fraction and ongoing symptoms.
Krakow, Lesser Poland VoivodeshipAges 18 years+ - NCT04851886Recruiting
Vision tool to guide robot therapy for stroke arm posture
This trial tests a vision-based system that detects your arm and posture during robot-assisted upper-arm therapy after a prior stroke. It may help the robot guide treatment more safely and accurately based on your movements and positioning.
Charlestown, MassachusettsAges 18–80 - NCT03452202Recruiting
Brain stimulation to improve speech after stroke
This trial studies whether gentle brain stimulation (tDCS) can improve speech after a stroke. It focuses on people with stroke-related apraxia of speech while carefully checking hearing, brain function, and safety with devices or metal.
New York, New YorkAges 18–99
Hear when a new Stroke (CVA) or Transient Ischemic Attack trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for stroke (cva) or transient ischemic attack?
- Yes. Clin2 currently lists 142 recruiting stroke (cva) or transient ischemic attack studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a stroke (cva) or transient ischemic attack trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a stroke (cva) or transient ischemic attack trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.